A carregar...
Debugging the Black Box
A better understanding of the mechanisms by which tumor rejection succeeds and fails is needed to improve immunotherapies. Here, Anagnostou and colleagues find that mutations predicted to be the most immunogenic are preferentially lost when cancer progresses through checkpoint blockade.
Na minha lista:
| Publicado no: | Cancer Discov |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341699/ https://ncbi.nlm.nih.gov/pubmed/28264866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-17-0070 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|